COMMUNIQUÉS West-GlobeNewswire

Sorrento Therapeutics Autologous Anti-CEA CAR-T Cell Therapy for Liver Metastases Demonstrates Therapeutic Activity in Stage IV Pancreas Cancer in a Phase 1b HITM-SURE Trial (NCT02850536)
05/03/2018
SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE ) (“Sorrento”), cellular therapy focused subsidiary, TNK Therapeutics, Inc. (“TNK”), and Surefire Medical, Inc., announced today [...]
Daré Bioscience, Inc. To Participate in the 30th Annual ROTH Conference
05/03/2018
SAN DIEGO, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced that Sabrina Martucci Johnson, President and Chief [...]
Epilepsy Foundation Awards $200,000 at ‘Shark Tank’ Competition for Innovative Products that Aim to Improve Epilepsy Treatment and Care
05/03/2018
LANDOVER, Md., March 05, 2018 (GLOBE NEWSWIRE) -- The Epilepsy Foundation announced the winners of the 2018 Shark Tank competition for innovative ideas in epilepsy and seizure treatment and care on February 22, 2018, at [...]
Momenta Pharmaceuticals to Webcast Presentation at Two Upcoming Investor Conferences
05/03/2018
CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that it [...]
Genocea to Present at Two March Investor Conferences
05/03/2018
CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA ), a biopharmaceutical company developing neoantigen cancer vaccines, today announced that Chip Clark, president and chief [...]
Neos Therapeutics to Present at the Cowen & Co. Annual Health Care Conference
05/03/2018
DALLAS and FORT WORTH, Texas, March 05, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS ), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR [...]
Onconova Therapeutics Announces License Agreement with Pint Pharma to Commercialize Rigosertib for Treatment of Myelodysplastic Syndromes in Latin America
05/03/2018
• Pint Pharma to Make Upfront Investment in Onconova • Onconova also Eligible to Receive up to $42.75 Million in Regulatory and Sales Milestones NEWTOWN, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, [...]
Krystal Biotech, Inc. to Present at the 30th Annual ROTH Conference
05/03/2018
PITTSBURGH, March 05, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (NASDAQ: KRYS ), a gene therapy company advancing “off-the-shelf,” treatments for dermatological diseases, today announced that Krish Krishnan, Chief [...]
pSivida To Present at the 30th Annual ROTH Conference
05/03/2018
WATERTOWN, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ: PSDV ) (ASX:PVA), a leader in the development of sustained release drug products and technologies, announced today that Nancy Lurker, President [...]
Todos Medical initiates clinical trial of its blood test for breast cancer in Kaplan Hospital, Rehovot, Israel for subjects undergoing breast cancer screening
05/03/2018
REHOVOT, Israel, March 05, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTC Pink:TOMDF) ( http://www.Todosmedical.com ) today announced the initiation of its first blinded clinical trial for TM-B1 – a simple blood test [...]
Avinger Announces Participation in Cowen and Company 38th Annual Health Care Conference
05/03/2018
REDWOOD CITY, Calif, March 05, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that the Company will be [...]
Jounce Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference
05/03/2018
CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE ), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers [...]
PhaseBio Announces Appointments to Board of Directors
05/03/2018
MALVERN, Pa., March 05, 2018 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapies for the treatment of orphan diseases, today announced the appointment of [...]
Synergy CHC Corp. to Present at 30th Annual Roth Conference on March 13th
05/03/2018
Westbrook, Maine, March 05, 2018 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (OTCQB: SNYR ), a leading omni-channel consumer health and beauty company, announced today that Jeffrey Kadanoff, Chief Financial Officer, is [...]
Immunomedics to Present at Cowen and Company 38th Annual Health Care Conference
05/03/2018
MORRIS PLANS, N.J., March 05, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that Michael Pehl, President and Chief Executive Officer, will present an [...]
AMAG Pharmaceuticals to Present at Upcoming Investor Conferences
05/03/2018
WALTHAM, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that company management will participate in the following investor conferences: Cowen and Company 38 th [...]
Emerald Health Therapeutics and Village Farms International Announce Cannabis Cultivation License for 1.1 Million Ft2 Delta 3 Greenhouse Operation
05/03/2018
VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (Emerald) (TSX-V: EHT ) (OTCQX:EMHTF) and Village Farms International, Inc. (Village Farms) (TSX: VFF ) (OTCQX:VFFIF) [...]
Avenue Therapeutics to Present at March Investor Conferences
05/03/2018
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI ) (“Avenue”), a company focused on the development and commercialization of intravenous (IV) tramadol, today announced that Lucy Lu, M [...]
Dermira’s Two Phase 3 Trials Evaluating Olumacostat Glasaretil in Patients with Acne Vulgaris Did Not Meet Co-Primary Endpoints
05/03/2018
Company expects to discontinue the program Conference call and webcast today at 8:30 a.m. ET / 5:30 a.m. PT MENLO PARK, Calif., March 05, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM ), a biopharmaceutical [...]

Pages